AS Kevelt-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:AS Kevelt - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011846
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:エストニア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AS Kevelt (Kevelt), a subsidiary of Pharmsynthez is a healthcare company that develops, manufactures and markets drug products. The company offers products which include concentrate solutions for infusion, endocervical gel, eye drops and other solutions. It also offers sub-contracting and distribution services. Kevelt provides pharma-co-vigilance facilities for maintenance of safety of pharmaceuticals administered to patients. The company’s sub-contracting services comprise sub-contract production, quality control, re-packaging and re-labeling and import services. Its products are used in treatment of obstetrics, peripheral vascular diseases and Glaucoma, elevated intraocular pressure. Kevelt is headquartered in Tallinn, Estonia.

AS Kevelt – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AS Kevelt, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AS Kevelt, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AS Kevelt, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AS Kevelt, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
AS Kevelt, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
AS Kevelt, Pharmaceuticals & Healthcare, Deal Details 10
Asset Transactions 10
Xenetic Biosciences Acquires Rights to Virexxa from Kevelt 10
Acquisition 11
Farmsintez to Acquire Stake in Kevelt for USD2.4 Million 11
Pharmsynthez Completes Acquisition Of Kevelt, Outsourced Manufacturer 12
AS Kevelt – Key Competitors 13
AS Kevelt – Key Employees 14
AS Kevelt – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
AS Kevelt, Pharmaceuticals & Healthcare, Key Facts 2
AS Kevelt, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AS Kevelt, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AS Kevelt, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AS Kevelt, Deals By Therapy Area, 2011 to YTD 2017 8
AS Kevelt, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Xenetic Biosciences Acquires Rights to Virexxa from Kevelt 10
Farmsintez to Acquire Stake in Kevelt for USD2.4 Million 11
Pharmsynthez Completes Acquisition Of Kevelt, Outsourced Manufacturer 12
AS Kevelt, Key Competitors 13
AS Kevelt, Key Employees 14

★海外企業調査レポート[AS Kevelt-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Banque Marocaine du Commerce Exterieur SA (BCE):企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Banque Marocaine du Commerce Exterieur SA" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. T …
  • B. Braun Melsungen AG-製薬・医療分野:企業M&A・提携分析
    Summary B. Braun Melsungen AG (B. Braun) is a global health care company. It offers products and solutions for therapy fields and applications including acute dialysis, infusion therapy, apheresis, interventional vascular, diagnostics and treatment, cardio-thoracic surgery, laparoscopy, degenerative …
  • Netsmart Technologies, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Netsmart Technologies, Inc. Mer …
  • Furiex Pharmaceuticals, Inc. (FURX):企業概要、財務及び戦略的SWOT分析
    Summary Furiex Pharmaceuticals, Inc. (Furiex) is a drug development company. The company develops and markets drug candidates. Its products include nesina, oseni and liovel, kazano, eluxadoline, priligy, novel fluoroquinolone JNJ-Q2, and SYR-472 trelagliptin. The company’s nesina is an oral drug use …
  • Enerchina Holdings Limited (622):企業の財務及び戦略的SWOT分析
    Summary Enerchina Holdings Limited (Enerchina), a subsidiary of Sinolink Worldwide Holdings Ltd. is a financial consulting company that provides corporate financial services. The company provides financial services such as securities brokerage, corporate finance advisory, investment advisory, money …
  • Hyflux Ltd:企業の戦略・SWOT・財務分析
    SummaryHyflux Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - D …
  • K3 Business Technology Group plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' K3 Business Technology Group pl …
  • Roblon A/Sの企業概要及び財務/SWOT分析
    Roblon A/S Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecasts …
  • Carrabba’s Italian Grill, Inc.:企業の戦略・SWOT・財務分析
    Carrabba's Italian Grill, Inc. - Strategy, SWOT and Corporate Finance Report Summary Carrabba's Italian Grill, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Bank of Jordan (BOJX):企業の財務及び戦略的SWOT分析
    Summary Bank of Jordan is a financial service provider that provides banking and financial services. The bank offers services such as corporate services, leasing services, retail services, SMEs services, and securities services. It also provides services such as car loan, mortgage, loan, personal lo …
  • Digger Resources Inc. (DIG.H):企業概要、財務及び戦略的SWOT分析
    Summary Digger Resources Inc. (Digger) is an oil and gas exploration service provider. The company provides high definition reservoir geochemistry (HDRG) technology for oil and natural gas exploration. It discovers and develops oil and natural gas reserves by detecting metallic and non-metallic ions …
  • Teijin Pharma Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Teijin Pharma Ltd (Teijin Pharma), a subsidiary of Teijin Ltd develops, manufactures and markets pharmaceutical and home healthcare products. The company offers a range of pharmaceutical products for the treatment of bone and joint diseases, respiratory diseases and cardiovascular and metabo …
  • Red Rock Resorts, Inc. (RRR):企業の財務・戦略的SWOT分析
    Red Rock Resorts, Inc. (RRR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • JSC SITRONICS:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' JSC SITRONICS Mergers and Acqui …
  • Henry Lamotte Group:戦略・SWOT・企業財務分析
    Henry Lamotte Group - Strategy, SWOT and Corporate Finance Report Summary Henry Lamotte Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Sevan Marine ASA (SEVAN):企業概要、財務及び戦略的SWOT分析
    Summary Sevan Marine ASA (Sevan Marine) is an independent energy utility company. The company, together with its subsidiaries specializes in designing, engineering and project execution of floating units for offshore applications including floating, production, storage and offloading units (FPSOs). …
  • Oxford Biodynamics Limited:(医療機器分野)企業M&A及び提携動向
    Summary Oxford Biodynamics Limited (Oxford Bio) is a biotechnology company. The company develops biomarker discovery platform. It discovers biomarker discovery platform EpiSwitch for the detection of aberrant gene expression. The company’s products is used for detection, monitoring and prognosis of …
  • Grinners Catering (Australia) Pty Ltd :企業の戦略・SWOT・財務分析
    SummaryGrinners Catering (Australia) Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of th …
  • Polyoak Packaging Group (Pty) Ltd.:企業の戦略・SWOT・財務分析
    SummaryPolyoak Packaging Group (Pty) Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the c …
  • Al-Sagr National Insurance Company PSC:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Al-Sagr National Insurance Company PSC" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Time …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆